...
首页> 外文期刊>American Journal of Cancer Research >miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer
【24h】

miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer

机译:miR-193b直接靶向STMN1并抑制结直肠癌的恶性表型

获取原文
           

摘要

Accumulating evidence suggests that aberrantly expressed microRNAs (miRNAs) contribute to the initiation and progression of human cancers. However, the underlying function of miR-193b in colorectal cancer (CRC) remains largely unexplored. Herein, we demonstrate that miR-193b is significantly down-regulated in CRC tissues compared with their normal counterparts. Kaplan-Meier analysis revealed that decreased miR-193b expression was closely associated with the shorter overall survival of patients with CRC. Through gain-and loss-of-function studies, we showed that miR-193b significantly suppressed CRC cell proliferation and invasion. In addition, bioinformatics analyses and luciferase reporter assays identified Stathmin 1 (STMN1) as the direct functional target of miR-193b in CRC. Furthermore, silencing of STMN1 resulted in a phenotype similar to that observed for overexpression of miR-193b, and restoration of STMN1 expression completely rescued the inhibitory effect of miR-193b in CRC cells. Taken together, our study implies the essential role of miR-193b in negatively regulating CRC progression, and a novel link between miR-193b and STMN1 in CRC.
机译:越来越多的证据表明,异常表达的microRNA(miRNA)有助于人类癌症的发生和发展。但是,miR-193b在结直肠癌(CRC)中的潜在功能仍未得到充分开发。在这里,我们证明,与正常对应物相比,miR-193b在CRC组织中显着下调。 Kaplan-Meier分析显示,miR-193b表达降低与CRC患者总体生存期缩短有密切关系。通过获得和丧失功能的研究,我们表明miR-193b显着抑制CRC细胞的增殖和侵袭。此外,生物信息学分析和萤光素酶报告基因分析确定Stathmin 1(STMN1)是CRC中miR-193b的直接功能靶标。此外,STMN1沉默后产生的表型与miR-193b过量表达所观察到的相似,而恢复STMN1的表达完全可以挽救miR-193b在CRC细胞中的抑制作用。综上所述,我们的研究暗示了miR-193b在负调控CRC进程中的重要作用,以及miR-193b和STMN1在CRC中的新型联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号